GPCR: Research and Technology for Drug Discovery
	IBC USA Conferences, Inc. , Loews Coronado Bay Resort * Coronado, CA May 15-16, 2000
	G Protein-Coupled Receptors account for approximately 60% of currently marketed pharmaceuticals and the human genome-sequencing project is confirming the family of GPCRs to be one of the largest. Due to their pharmacological tractability, history of providing effective therapeutics and the developing speed of identification and target validation of orphan GPCRs, novel insights into their basic mechanisms of action are rapidly being converted into ligand screens. IBC's GPCR Conference is one of a kind and is in its 5th successful year. Join the many that have benefited from this cutting edge program.
	Organized by:	IBC USA Conferences, Inc.
	Deadline for Abstracts:	-
	Registration:	Phone (508) 616-5550 Email reg@ibcusa.com Fax (508) 616-5533 Online www.ibc-lifesci.com/2499 Mail IBC USA Conferences, Inc., 1 Research Drive, Suite 400A, Westborough, MA 01581
	Email for Requests and Registration:	jprudhomme@ibcusa.com
	Posted by: James Prudhomme   Host: 209.6.93.46 date: April 10, 2000 21:27:45 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.